A general system for targeting MHC class II-antigen complex via a single adaptable loop

Nat Biotechnol. 2025 Oct;43(10):1673-1682. doi: 10.1038/s41587-024-02466-y. Epub 2024 Dec 13.

Abstract

Major histocompatibility complex class II (MHCII) bound to a peptide antigen mediates interactions between CD4+ T cells and antigen-presenting cells. Targeting peptide-MHCII with T cell antigen receptors (TCRs) and TCR-like antibodies has shown promise for autoimmune diseases and microbiome tolerance. To develop a general targeting approach, we introduce targeted recognition of antigen-MHC complex reporter for MHCII (TRACeR-II) for the rapid development of peptide-specific MHCII binders. TRACeR-II binders have a small helical bundle scaffold and use a single loop to recognize peptide-MHCII, which offers versatility and enables structural modeling of the interactions to target MHCII antigens. We demonstrate rapid generation of TRACeR-II binders to multiple molecules with affinities in the low-nanomolar to low-micromolar range, comparable to best-in-class TCRs and antibodies. Through computational protein design, we created specific binding sequences in silico from only the sequence of a severe acute respiratory syndrome coronavirus 2 peptide. TRACeR-II provides a straightforward approach to target antigen-MHCII without relying on combinatorial selection on complementarity-determining region loops.

MeSH terms

  • Histocompatibility Antigens Class II* / chemistry
  • Histocompatibility Antigens Class II* / immunology
  • Histocompatibility Antigens Class II* / metabolism
  • Humans
  • Peptides / chemistry
  • Peptides / immunology
  • Protein Binding
  • Receptors, Antigen, T-Cell / immunology
  • SARS-CoV-2 / immunology

Substances

  • Histocompatibility Antigens Class II
  • Peptides
  • Receptors, Antigen, T-Cell